Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 4, 2025
Although
photothermal
therapy
(PTT)
can
induce
antitumour
immunity,
the
mechanisms
underlying
its
effects
in
pancreatic
cancer
(PC)
require
further
exploration.
In
this
study,
mechanism
of
action
PTT
and
connection
to
pyroptosis
as
well
therapeutic
potential
alone
combination
with
STING
agonists,
were
investigated.
addition,
a
biomarker
PC
was
found
stratify
patients
who
are
suitable
for
PTT.
We
explored
whether
vitro
evaluated
efficacy
immunity-inducing
ability
combined
agonist
(c-di-GMP)
immune
adjuvant
vivo
PC.
also
gasdermin
D
(GSDMD)
expression
tumour
tissues
investigated
drug
sensitivity
patient-derived
organoids
(PDOs)
differential
GSDMD
expression.
Our
study
demonstrated
that
local
induces
via
caspase-1/GSDMD
pathway
elicits
immunity.
exhibits
better
than
while
limiting
distant
metastasis,
enhances
response
by
promoting
dendritic
cell
maturation,
increasing
frequency
infiltrating
T
cells,
converting
macrophages
from
M2
M1
phenotype.
we
is
highly
expressed
overexpression
might
suggest
increased
resistance
chemotherapy
benefits
therapy.
confirmed
PDOs
higher
less
sensitive
chemotherapeutic
agent
(5-Fluorouracil)
lower
expression,
making
new
identifying
may
benefit
work,
c-di-GMP
used
an
treat
first
time,
results
provide
clues
development
novel
immunotherapies
simultaneously
suppress
primary
tumours
metastases.
has
great
selection
individualized
treatment
modalities.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: April 24, 2024
Abstract
Multi-modal
combination
therapy
is
regarded
as
a
promising
approach
to
cancer
treatment.
Combining
chemotherapy
and
phototherapy
an
essential
multi-modal
endeavor.
Ivermectin
(IVM)
potent
antiparasitic
agent
identified
having
potential
antitumor
properties.
However,
the
fact
that
it
induces
protective
autophagy
while
killing
tumor
cells
poses
challenge
its
further
application.
IR780
iodide
(IR780)
near-infrared
(NIR)
dye
with
outstanding
photothermal
(PTT)
photodynamic
(PDT)
effects.
hydrophobicity,
instability,
low
uptake
of
limit
clinical
applications.
Here,
we
have
structurally
modified
hydroxychloroquine,
inhibitor,
synthesize
novel
compound
H780.
H780
IVM
can
form
H780-IVM
nanoparticles
(H-I
NPs)
via
self-assembly.
Using
hyaluronic
acid
(HA)
modify
H-I
NPs,
nano-delivery
system
HA/H780-IVM
(HA/H-I
was
synthesized
for
chemotherapy-phototherapy
colorectal
(CRC).
Under
NIR
laser
irradiation,
HA/H-I
NPs
effectively
overcame
limitations
exhibited
cytotoxicity.
In
vitro
in
vivo
experiment
results
showed
excellent
anti-CRC
Therefore,
our
study
provides
strategy
CRC
treatment
could
enhance
chemo-phototherapy
by
modulating
autophagy.
RSC Advances,
Journal Year:
2025,
Volume and Issue:
15(5), P. 3098 - 3109
Published: Jan. 1, 2025
Tumor
hypoxia
still
severely
limits
the
antitumor
efficiency.
Herein,
a
free-radical
initiator-based
carrier-free
smart
nanobomb
with
oxygen-independent
trimodal
therapeutic
effects
for
targeted
therapy
of
hypoxic
breast
tumor
at
low
dose.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 4, 2025
Although
photothermal
therapy
(PTT)
can
induce
antitumour
immunity,
the
mechanisms
underlying
its
effects
in
pancreatic
cancer
(PC)
require
further
exploration.
In
this
study,
mechanism
of
action
PTT
and
connection
to
pyroptosis
as
well
therapeutic
potential
alone
combination
with
STING
agonists,
were
investigated.
addition,
a
biomarker
PC
was
found
stratify
patients
who
are
suitable
for
PTT.
We
explored
whether
vitro
evaluated
efficacy
immunity-inducing
ability
combined
agonist
(c-di-GMP)
immune
adjuvant
vivo
PC.
also
gasdermin
D
(GSDMD)
expression
tumour
tissues
investigated
drug
sensitivity
patient-derived
organoids
(PDOs)
differential
GSDMD
expression.
Our
study
demonstrated
that
local
induces
via
caspase-1/GSDMD
pathway
elicits
immunity.
exhibits
better
than
while
limiting
distant
metastasis,
enhances
response
by
promoting
dendritic
cell
maturation,
increasing
frequency
infiltrating
T
cells,
converting
macrophages
from
M2
M1
phenotype.
we
is
highly
expressed
overexpression
might
suggest
increased
resistance
chemotherapy
benefits
therapy.
confirmed
PDOs
higher
less
sensitive
chemotherapeutic
agent
(5-Fluorouracil)
lower
expression,
making
new
identifying
may
benefit
work,
c-di-GMP
used
an
treat
first
time,
results
provide
clues
development
novel
immunotherapies
simultaneously
suppress
primary
tumours
metastases.
has
great
selection
individualized
treatment
modalities.